Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Explore the best credit cards for collecting travel points. Start earning rewards for your next adventure.
19,390 articlesSarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Wells Fargo and Jefferies boosted ONEOK on Wednesday, citing a structural shift in energy demand tied to Iran-related...
SCHB and VTV offer low-cost ways to invest in U.S. stocks, but they serve different purposes. One captures the broad ...
NVIDIA still leads the AI chip race, but investors are spreading bets downstream to adjacent AI opportunities as the ...
As Rex gears up to report Q4 2025 results, investors should focus on growth drivers, margins, and the outlook. This g...
After a stunning quarterly update, Micron stock tumbled on fears about memory cycles. This guide breaks down why the ...
Two Harbors Investment will terminate its merger with UWM and accept an all-cash bid from CrossCountry worth roughly ...
A new ETF focused on CTAs began trading this week, giving U.S. investors direct exposure to trend-following across mu...
Chevron Corp's CEO warned that the closure of the Strait of Hormuz could tighten global oil supply and slow economies...
Ethereum stabilizes around the $1,800 support zone as traders eye a potential breakout above $2,400. Risk remains as ...
Bitcoin hovers around $82,000 as an AI-generated forecast maps multiple year-end paths. The scenarios hinge on ETF de...
Investors are watching novavax (nvax) 2025 earnings closely as the company pivots its vaccine portfolio. This article...